Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.58B |
| 2 |
Amphenol
APH
|
+$1.06B |
| 3 |
Eli Lilly
LLY
|
+$896M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$780M |
| 5 |
Snowflake
SNOW
|
+$615M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.24B |
| 2 |
NVIDIA
NVDA
|
+$1.89B |
| 3 |
Mercado Libre
MELI
|
+$1.5B |
| 4 |
Netflix
NFLX
|
+$1.32B |
| 5 |
Nike
NKE
|
+$826M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.63% |
| 2 | Communication Services | 15.64% |
| 3 | Consumer Discretionary | 12.05% |
| 4 | Healthcare | 9.65% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Denali Therapeutics
DNLI
$3.97B
| – | – |
-45,445
| Closed | -$660K |
|
602
Darden Restaurants
DRI
$24.4B
| – | – |
-19,525
| Closed | -$3.72M |
|
603
Brinker International
EAT
$9.66B
| – | – |
-3,583
| Closed | -$454K |
|
|
EXAS
604
DELISTED
Exact Sciences
EXAS
| – | – |
-306,196
| Closed | -$16.8M |
|
605
Healthcare Services Group
HCSG
$1.53B
| – | – |
-52,077
| Closed | -$876K |
|
606
Hilton Grand Vacations
HGV
$3.55B
| – | – |
-15,630
| Closed | -$653K |
|
607
Herbalife
HLF
$1.29B
| – | – |
-79,903
| Closed | -$674K |
|
|
HUT
608
Hut 8
HUT
$10.9B
| – | – |
-11,736
| Closed | -$409K |
|
609
Integra LifeSciences
IART
$1.34B
| – | – |
-42,841
| Closed | -$614K |
|
610
Intuit
INTU
$89B
| – | – |
-8,220
| Closed | -$5.61M |
|
611
InvenTrust Properties
IVT
$2.59B
| – | – |
-30,143
| Closed | -$863K |
|
612
Kennametal
KMT
$2.52B
| – | – |
-40,537
| Closed | -$848K |
|
613
Kura Oncology
KURA
$850M
| – | – |
-56,731
| Closed | -$502K |
|
614
Leggett & Platt
LEG
$1.31B
| – | – |
-96,256
| Closed | -$855K |
|
615
Magnite
MGNI
$3.55B
| – | – |
-40,431
| Closed | -$881K |
|
616
monday.com
MNDY
$3.94B
| – | – |
-196,538
| Closed | -$38.1M |
|
617
Mueller Water Products
MWA
$4.16B
| – | – |
-58,738
| Closed | -$1.5M |
|
618
Neurocrine Biosciences
NBIX
$16.6B
| – | – |
-519,953
| Closed | -$73M |
|
619
New Jersey Resources
NJR
$5.58B
| – | – |
-50,916
| Closed | -$2.45M |
|
|
620
Nike
NKE
$61.9B
| – | – |
-11,838,528
| Closed | -$826M |
|
621
NETGEAR
NTGR
$635M
| – | – |
-43,425
| Closed | -$1.41M |
|
|
NVO
622
Novo Nordisk
NVO
$209B
| – | – |
-1,226,004
| Closed | -$68M |
|
623
Paycom
PAYC
$9.69B
| – | – |
-170,990
| Closed | -$35.6M |
|
624
Procter & Gamble
PG
$339B
| – | – |
-382,083
| Closed | -$58.7M |
|
625
Pultegroup
PHM
$25.3B
| – | – |
-9,411
| Closed | -$1.24M |
|
Similar funds
Jennison Associates's Q4 2025 Portfolio in Review
As of Q4 2025, Jennison Associates held 652 positions worth $167B, down 3% from $172B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates withdrew a net $7.12B in Q4 2025, closing 78 positions and reducing 263 holdings. Its most notable exit was Nike, an estimated $826M position sold in full.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Merck worth $585M.
- Jennison Associates's largest Q4 2025 buy was Merck: 5,559,488 shares worth $585M.
- Jennison Associates added most to Advanced Micro Devices in Q4 2025, an estimated $1.58B increase.
- Jennison Associates's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $2.24B.
- Jennison Associates fully exited Nike in Q4 2025, selling an estimated $826M.
- Jennison Associates's ten largest holdings make up 48% of its $167B portfolio in Q4 2025.
- Jennison Associates opened 92 new positions and closed 78 in Q4 2025.
- Jennison Associates's portfolio value fell 3% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.